Discover 1,106 paid clinical trials in Salt Lake City, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
There are a wide variety of studies currently listed in Salt Lake City, focusing on conditions such as autism, celiac disease, and osteoporosis. The city's leading medical research institutions are actively recruiting participants, providing access to cutting-edge treatments and therapies for both healthy volunteers interested in paid clinical trials and individuals in need of studies for specific health conditions.
Filter
2
Filter results
Results: 1,106
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: West Valley City UT, Los Angeles CA, Fort Worth TX
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07517198
Phase 1, Recruiting
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
for
Esophageal Squamous Cell Carcinoma,
Location: West Valley City UT, Spokane WA, Fort Worth TX,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07503808
Phase 1, Recruiting
Study in Advanced Solid Tumor Patients
for
Advanced Solid Tumor
Location: West Valley City UT, San Antonio TX, Houston TX,
Sponsor: Callio Therapeutics
Sex: All
Age: 18+
Code: NCT07300943
Phase 1, Phase 2, Recruiting
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: West Valley City UT, San Antonio TX, Grand Rapids MI,
Sponsor: Ottimo Pharma Limited
Sex: All
Age: 18+
Code: NCT07266428
Phase 1, Phase 2, Recruiting
First-in-human Study of 7MW4911 in GI Cancer
for
GI Cancers
Location: West Valley City UT, Seattle WA, New York NY,
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Sex: All
Age: 18+
Code: NCT07216560
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
for
Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC),
Location: West Valley City UT, Vancouver, San Antonio TX, Toronto,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07223047
Phase 1, Phase 2, Recruiting
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
for
Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-),
Location: West Valley City UT, Duarte CA, San Antonio TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07318805
Phase 1, Recruiting
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
for
Colorectal Cancer, Pancreatic Cancer,
Location: West Valley City UT, San Antonio TX, Fairfax VA,
Sponsor: PAQ Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07300150
Phase 1, Recruiting
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
for
Neoplasm Malignant
Location: West Valley City UT, Las Vegas NV, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07209111
Phase 2, Recruiting
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
for
Solid Tumours
Location: West Valley City UT, Los Angeles CA, Orange CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07160725
Phase 1, Phase 2, Recruiting
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
for
Prostatic Neoplasms
Location: West Valley City UT, Grand Rapids MI, Sarasota FL
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT07746713
Phase 1, Recruiting
First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies
for
Participants With Advanced Solid Tumor Malignancies
Location: West Valley City UT, San Antonio TX, Houston TX,
Sponsor: VelaVigo Bio Inc
Sex: All
Age: 18+
Code: NCT07136779
Phase 1, Phase 2, Recruiting
A Study of LY4175408 in Participants With Advanced Cancer
for
Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,
Location: West Valley City UT, Stanford CA, St Louis MO,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07046923
Phase 1, Recruiting
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
for
Triple Negative Breast Cancer (TNBC),
Location: West Valley City UT, San Antonio TX, Houston TX,
Sponsor: ProteinQure Inc.
Sex: All
Age: 18+
Code: NCT07190469
Phase 1, Recruiting
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
for
Advanced Solid Tumor
Location: West Valley City UT, San Antonio TX, Madison WI,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07070232
Phase 1, Phase 2, Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for
ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: West Valley City UT, Fort Worth TX, Dallas TX,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18 - 70+
Code: NCT07540572
Phase 1, Recruiting
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: West Valley City UT, Los Angeles CA, San Antonio TX,
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05985655
Phase 1, Phase 2, Recruiting
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma,
Location: West Valley City UT, Los Angeles CA, Irving TX,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07488676
Phase 1, Phase 2, Recruiting
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: West Valley City UT, Las Vegas NV, Duarte CA,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07029399
Phase 1, Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
for
PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer
Location: Salt Lake City UT, Los Angeles CA, Dallas TX,